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The covid-19 pandemic has created profound ethical challenges
in health and social care, not only for current decisions about
individuals but also for longer term and population level policy
decisions. Already covid-19 has generated ethical questions
about the prioritisation of treatment, protective equipment, and
testing; the impact of covid-19 strategies on patients with other
health conditions; the approaches taken to advance care planning
and resuscitation decisions1; and the crisis in care homes.
Ethical questions continue to multiply as the pandemic
progresses and new evidence emerges, including how best to
distribute any new vaccines and treatments; how best to respond
to evidence that disease severity and mortality are substantially
greater in ethnic minority populations2; how to prioritise patients
for care as medical services re-open; how to manage assessment
of immunity and its implications; and how the health system
should be configured to manage any future peaks in cases.
Science and values
The UK government repeatedly states that it is “following the
science” by heeding the advice provided through the Scientific
Advisory Group for Emergencies (SAGE). However, this
implies that the science alone will tell us what to do. Not only
does this rhetoric shift the responsibility for difficult decisions
on to “the science”, it is also wrong. Science may provide
evidence on which to base decisions, but our values will
determine what we do with that evidence and how we select the
evidence to use. It is disingenuous and misleading to imply that
value-free science leads the way. Both science and policy are
value laden.
Values questions are being addressed primarily by professional
organisations, although the UK government has independent
advice, for example, from the Moral and Ethical Advisory
Group.3-6 Despite such efforts to plot an ethical path, the current
approach is piecemeal, confusing, and risks needless duplication
of effort. Concerns are mounting about a lack of transparency
around the ethical agenda underpinning decisions, a lack of
coordination, and the absence of clear national leadership.7-12
Ethical planning
As the UK prepares to emerge from lockdown, we urge our
leaders to develop an ethical plan with at least the following
three features.
Firstly, there should be nationally led and coordinated
development of transparent, publicly shared ethical guidance
that can provide the basis for clear, consistent, and defensible
decisions in all healthcare and policy settings across the country.
Such guidance could then be tailored to specific contexts.9
Whatever its reach, guidance will require consultation with
stakeholders with relevant expertise, including patients.
Development processes must be transparent and the conclusions
publicly accessible.
Secondly, ethics support structures should be formalised,
coordinated, resourced, and embedded throughout the health
and social care system to support the interpretation and
application of national guidance. Ethics support can enhance
the clarity, consistency, and defensibility of decisions made
across the country and help share the substantial burden of
urgent and complex decision making.
Ethics support services, such as clinical ethics committees, exist
throughout the UK, although provision varies widely. Before
and during the pandemic, the UK Clinical Ethics Network has
sought to help coordinate ethics support and has offered advice
on setting up such services.3 However, the network is a charity,
reliant on volunteers (like most ethics support currently offered
in the UK). A recent legislative proposal, drafted after several
high profile legal cases, sought to increase “access to clinical
ethics committees throughout NHS hospitals.”13 Covid-19
highlights the urgent need for more formal clinical ethics support
embedded across the health and social care system, and not just
in hospitals.
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Thirdly, research is required to inform and support the
development of ethical policy and guidance, and the
interpretation of both. The UK has abundant expertise in
healthcare ethics, supported by organisations such as the
Nuffield Council on Bioethics, the Wellcome Trust, and research
councils. Recent funding calls for urgent covid-19 research
highlight the need for research on the ethical dimensions of the
pandemic.14 These organisations could coordinate to commission
timely, focused, ethical research to help answer the many
remaining ethical questions about pandemic responses.
None of the above can succeed without the overt support of
leaders from government, the NHS and social care, and Public
Health England. In plotting the way through this pandemic, we
need to follow the ethics, not just the science. Every institution
and organisation involved in the response must follow ethical
principles, uphold ethical standards, and be publicly accountable
for the decisions they make.
We thank Suzanne Shale for her invaluable input throughout the conception and
writing of this article.
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